Momenta reports a bigger quarterly loss
August 7, 2007 01:53 PM
E-mail|
|Comments
()|
Text size
–
+
Momenta Pharmaceuticals Inc. said its second-quarter loss widened on higher operating costs and lower revenue.
The Cambridge biotechnology company posted a loss of $18.8 million, or 53 cents per share, compared with a loss of $12.6 million, or 41 cents per share, in the year-earlier period.
Revenue for the quarter declined 22 percent, to $4.2 million.
(AP)
Comment
Permalink
E-mail
